Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women & their male partners in Pune India - Phase I study

Indian Journal of Medical Research

Volumn 123, Issue 4, 2006, Pages 547-552

  Joglekar, Neelam S ^a   Joshi, S N ^a   Navlakha, S N ^a   Katti, U R ^a   Mehendale, S M ^a  

^a NATIONAL AIDS RESEARCH INSTITUTE   (India)

Author keywords

Acceptability; HIV; Microbicide; Praneem polyherbal tablet; Scores

Indexed keywords

ALGINIC ACID; AZADIRACHTA INDICA EXTRACT; MICROBICIDE; SAPONIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HERBAL MEDICINE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; INTERVIEW; LABORATORY TEST; MALE; MEDICAL ASSESSMENT; MEDICAL RESEARCH; ODOR; PATIENT ATTITUDE; PHASE 1 CLINICAL TRIAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; VAGINA DISCHARGE; VAGINA DISEASE; VAGINAL PRURITUS;

ADULT; ANTI-INFECTIVE AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INDIA; MALE; PATIENT COMPLIANCE; PHYTOTHERAPY; PLANT EXTRACTS; QUININE; SEXUAL PARTNERS; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 33745477882     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Surveillance for AIDS cases in India as reported to NACO as on 31st March 2004 (webpage: http./www.naco.nic.in/AIDS Cases/overv.htm), accessed on May 22, 2004.
2. Bhattacharya G. Sociocultural and behavioral contexts of condom use in heterosexual married couples in India: challenges to the HIV prevention program. Health Educ Behav 2004; 31 : 101-17.
3. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996; 10 (Suppl 3) : S43-51.
4. D'Cruz OJ, Uckun FM. Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des 2004; 10 : 315-36.
5. Biswas K, Chattopadhyay I, Banerjee RK, Bandhopadhyay U. Biological activity and medicinal properties of neem (Azadirachta Indica). Curr Sci 2002; 82 : 1336-45.
6. Joshi SN, Katti U, Godbole S, Bharucha K, Kumar BK, Kulkarni S, et al. Phase I safety study of Praneem polyherbal vaginal tablet use among HIV-uninfected women in Pune, India. Trans R Soc Trop Med Hyg 2005; 99 : 769-74.
7. Watts CH, Thompsom WA, Heise LL. The effectiveness of microbicides for HIV prevention. Abstract Number 33161, abstract book, p 624. 12th World AIDS conference, Geneva, Switzerland, June 28-July 3, 1998.
8. Mobilization for microbicides: The Decisive Decade. The Rockefeller Foundation microbicide initiative. Available at http://www.rockfound.org/ documents/488/rep1_summary.pdf, accessed on August 20, 2004.
9. Hammett TM, Mason TH, Joanis CL, Foster SE, Harmon P, Robles RR, et al. Acceptability of formulations and application methods for vaginal microbicide among drug-involved women: results of product trials in three cities. Sex Transm Dis 2000; 27 : 119-26.
10. Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, et al. The acceptability of an investigational vaginal microbicide PRO 2000 Gel, among women in Phase I clinical trial. J Womens Health (Larchmt) 2003; 12 : 655-66.
11. Moon MW, Khumalo-Sakutukwa GN, Heiman JE, Mbizvo MT, Padian NS. Vaginal microbicides for HIV/ STI prevention in Zimbabwe: what key informants say. J Transcult Nurs 2002; 13 : 19-23.
12. Ramjee G, Gouws E, Andrews A, Myer L, Weber AE. The acceptability of a vaginal microbicide among south African men. Int Fam Plann Perspect 2001; 27 : 164-70.
13. Elias C, Coggins C. Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? J Womens Health Gend Based Med 2001; 10 : 163-73.
14. Bentley ME, Fullem AM, Tolley EE, Kelly MS, Joglekar NS, Srirak N, et al. Acceptability of a microbicide among women and their partners in a 4-country Phase I trial. Am J Public Health 2004; 94 : 1159-64.
15. Raymond E, Alvarado G, Ledesma L, Diaz S, Bassol S, Morales E, et al. Acceptability of two spermicides in five countries. Contraception 1999; 60 : 45-50.
16. Bentley M, Morrow K, Fullem A, Chesney MA, Horton SD, Rosenberg Z, et al. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann Perspect 2000; 32 : 184-8.
17. Turner CF. Measuring the acceptability of microbicides: Problems and principles. AIDS 2000; 15 : S31-2.
18. UNAIDS, Report on the Global AIDS Epidemic 2004. 4th global report. p27-28. Joint United Nations Programme on HIV/AIDS (UNAIDS). Geneva, Switzerland, July 2004.